{
  "title": "Regulatory Compliance",
  "subtitle": "FDA & CE Mark Approval Pathways for AI/ML Medical Devices",
  "tooltipContent": "This section outlines the regulatory pathways for AI-based medical devices in the US (FDA) and Europe (CE Mark). Understanding these requirements is essential for commercializing medical AI software.",
  "currentStatus": "‚ö†Ô∏è Current Status",
  "disclaimer": "This application is currently for research and educational purposes only. It is NOT FDA-approved or CE-marked as a medical device. This information is provided for educational purposes about regulatory pathways.",
  "fdaTitle": "üá∫üá∏ FDA Approval Pathway (United States)",
  "fdaTooltip": "The Food and Drug Administration (FDA) regulates medical devices in the United States through various pathways depending on risk classification and device type.",
  "deviceClassification": "Device Classification",
  "likelyClassification": "Likely Classification:",
  "classII": "Class II Medical Device",
  "classIIDescription": "AI-based skin lesion analysis systems typically fall under Class II, requiring 510(k) premarket notification and demonstration of substantial equivalence to a predicate device.",
  "pathway510k": "510(k) Premarket Notification Pathway",
  "step1Title": "Predicate Device Identification",
  "step1Description": "Identify legally marketed device with similar intended use and technological characteristics",
  "step2Title": "Clinical Validation",
  "step2Description": "Conduct clinical studies demonstrating safety and effectiveness (typically 100-200+ patients)",
  "step3Title": "Software Documentation",
  "step3Description": "Provide software validation per FDA guidance (IEC 62304, cybersecurity, algorithm transparency)",
  "step4Title": "510(k) Submission",
  "step4Description": "Submit comprehensive documentation including clinical data, software validation, and labeling",
  "step5Title": "FDA Review",
  "step5Description": "FDA review typically takes 90 days (may require additional information requests)",
  "keyFDARequirements": "Key FDA Requirements for AI/ML Devices",
  "requirement1": "Clinical validation with diagnostic accuracy metrics (sensitivity, specificity, PPV, NPV)",
  "requirement2": "Algorithm transparency and explainability documentation",
  "requirement3": "Training data documentation (sources, diversity, bias mitigation)",
  "requirement4": "Software lifecycle management (IEC 62304 compliance)",
  "requirement5": "Cybersecurity risk management",
  "requirement6": "Post-market surveillance plan for model performance monitoring",
  "requirement7": "Quality System Regulation (QSR) compliance (21 CFR Part 820)",
  "estimatedTimeline": "Estimated Timeline & Costs",
  "developmentTime": "Development Time",
  "devTime": "12-24 months",
  "totalCost": "Total Cost",
  "cost": "$500K - $2M",
  "clinicalStudy": "Clinical Study",
  "patients": "100-200+ patients",
  "fdaReview": "FDA Review",
  "reviewTime": "3-6 months",
  "ceMarkTitle": "üá™üá∫ CE Mark Pathway (European Union)",
  "ceMarkTooltip": "The CE Mark is required for medical devices sold in the European Union. The Medical Device Regulation (MDR) 2017/745 governs AI-based medical software.",
  "classificationMDR": "Device Classification (MDR)",
  "classIIaIIb": "Class IIa or Class IIb",
  "mdrDescription": "Under MDR 2017/745, AI software for diagnosis typically qualifies as Class IIa (supporting diagnosis) or Class IIb (influencing patient management decisions). Classification depends on intended use and risk level.",
  "ceMarkConformity": "CE Mark Conformity Assessment",
  "ceStep1Title": "Classification Determination",
  "ceStep1Description": "Apply MDR classification rules (especially Rule 11 for software)",
  "ceStep2Title": "Notified Body Selection",
  "ceStep2Description": "Engage EU-recognized Notified Body for conformity assessment (required for Class IIa/IIb)",
  "ceStep3Title": "Technical Documentation",
  "ceStep3Description": "Prepare comprehensive technical file per MDR Annex II and III",
  "ceStep4Title": "Clinical Evaluation",
  "ceStep4Description": "Conduct clinical evaluation per MDR Annex XIV (clinical data required)",
  "ceStep5Title": "Quality Management System",
  "ceStep5Description": "Implement ISO 13485 certified QMS",
  "ceStep6Title": "Declaration of Conformity",
  "ceStep6Description": "Issue DoC and affix CE mark after Notified Body approval",
  "keyMDRRequirements": "Key MDR Requirements for AI/ML Devices",
  "mdrReq1": "Clinical evaluation report with clinical data",
  "mdrReq2": "Risk management per ISO 14971",
  "mdrReq3": "Software lifecycle per IEC 62304",
  "mdrReq4": "Usability engineering per IEC 62366",
  "mdrReq5": "Post-market surveillance system (PMSS)",
  "mdrReq6": "Unique Device Identification (UDI)",
  "mdrReq7": "EUDAMED database registration",
  "ceDevTime": "12-18 months",
  "ceCost": "$300K - $1M",
  "notifiedBodyFees": "Notified Body Fees",
  "nbFees": "$50K - $150K",
  "nbReview": "NB Review",
  "aimlTitle": "ü§ñ AI/ML Specific Regulatory Considerations",
  "aimlTooltip": "AI and machine learning medical devices have unique regulatory considerations including algorithm transparency, continuous learning, and bias mitigation.",
  "algorithmTransparency": "Algorithm Transparency & Explainability",
  "transparency1": "Detailed description of algorithm architecture and training methodology",
  "transparency2": "Training dataset characteristics (size, diversity, demographics, sources)",
  "transparency3": "Explainability features (e.g., Grad-CAM heatmaps, attention maps)",
  "transparency4": "Performance metrics across different patient populations",
  "continuousLearning": "Continuous Learning & Model Updates",
  "learningDescription": "FDA's \"Predetermined Change Control Plan\" allows certain algorithm modifications without new 510(k) submission. Requirements include:",
  "learning1": "Pre-specified modification protocol in original submission",
  "learning2": "Real-world performance monitoring system",
  "learning3": "Version control and change documentation",
  "learning4": "Revalidation testing protocol for updates",
  "biasMitigation": "Bias Mitigation & Fairness",
  "bias1": "Performance evaluation across demographic groups (age, sex, race, skin type)",
  "bias2": "Strategies to address identified disparities",
  "bias3": "Diverse and representative training data",
  "bias4": "Ongoing bias monitoring in post-market surveillance",
  "additionalResources": "Additional Resources",
  "fdaGuidanceLabel": "FDA AI/ML Guidance:",
  "fdaGuidanceLink": "FDA.gov - Artificial Intelligence/Machine Learning Software as Medical Device",
  "euMDRLabel": "EU MDR:",
  "euMDRLink": "Regulation (EU) 2017/745 on Medical Devices",
  "standardsLabel": "Standards:",
  "standardsLink": "IEC 62304 (Software), ISO 13485 (QMS), ISO 14971 (Risk Management)",
  "guidanceLabel": "Guidance Documents:",
  "guidanceLink": "Good Machine Learning Practice for Medical Device Development (FDA, Health Canada, MHRA)"
}